Increased Opioid Usage

Published Online: Wednesday, January 8, 2014
Follow Pharmacy_Times:
In this video, Mary Lynn McPherson, PharmD, professor and vice chair at the University of Maryland School of Pharmacy, discusses the dramatic increase in the use of opioids in the United States. This is the first in a series of videos in which Dr. McPherson argues in favor of categorizing hydrocodone combination products as Schedule II drugs. Jeff Fudin, PharmD, will argue against doing so. (Drs. McPherson and Fudin were assigned to take these positions for a session at the American Society of Health-System Pharmacists 2013 Midyear Clinical Meeting in Orlando, and their arguments do not necessarily reflect their personal positions on the issue.)

These videos were filmed at the ASHP 2013 Midyear Clinical Meeting in Orlando.

Related Articles
Although pharmacies can legally dispense remaining refills of prescriptions for rescheduled hydrocodone combination products submitted prior to October 6, 2014, over the next 6 months, many drug chains have chosen not to honor those refills.
Patients with irritable bowel syndrome cannot block pain signals from the gut as easily as those without the gastrointestinal condition.
All drugs containing the opioid hydrocodone have been reclassified as Schedule II controlled substances, prohibiting pharmacies from recognizing refills and phoned-in prescriptions for those medications.
Latest Issues
$auto_registration$